Development of hypertrophic cardiomyopathy in perilipin-1 nullmice with adipose tissue dysfunction

Cardiovascular Research

Volumn 105, Issue 1, 2015, Pages 20-30

  Liu, Shangxin ^a,c   Geng, Bin ^a   Zou, Liangqiang ^a   Wei, Suning ^a   Wang, Weiyi ^a   Deng, Jingna ^a   Xu, Chong ^a,b   Zhao, Xiaojing ^a   Lyu, Ying ^a   Su, Xueying ^a   Xu, Guoheng ^a  

^a PEKING UNIVERSITY   (China)

^b Astronaut Research and Training Center of China   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Adipose tissue dysfunction; Hypertrophic cardiomyopathy; Lipid metabolism; Lipolysis; Perilipin

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; FATTY ACID SYNTHASE; GLUCOSE; GLYCEROL; INSULIN; MALONALDEHYDE; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; PERILIPIN; PERILIPIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARRIER PROTEIN; FATTY ACID; PHOSPHOPROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE DYSFUNCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY FAT; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; EPIDIDYMIS FAT; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; HYPERTROPHIC CARDIOMYOPATHY; INSULIN RESISTANCE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIPID OXIDATION; LIPID STORAGE; LIPODYSTROPHY; LIPOLYSIS; LIPOTOXICITY; MALE; METABOLIC DISORDER; MOUSE; MYOFILAMENT; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE; 129 MOUSE; ANIMAL; CARDIOMYOPATHY, HYPERTROPHIC; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FATTY ACIDS; LIPID METABOLISM; LIPOLYSIS; MALE; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PHOSPHOPROTEINS;

EID: 84929074460     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu214     Document Type: Article

References (40)

1. Brasaemle DL. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007;48:2547-2559.
2. Greenberg AS, Egan JJ, Wek SA, MoosMCJr, Londos C, Kimmel AR. Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes. Proc Natl Acad Sci USA 1993;90:12035-12039.
3. Brasaemle DL, Rubin B, Harten IA, Gruia-Gray J, Kimmel AR, Londos C. Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 2000;275:38486-38493.
4. Sztalryd C, XuG, DorwardH, Tansey JT, Contreras JA, Kimmel AR, Londos C. PerilipinA is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol 2003;161:1093-1103.
5. Granneman JG, Moore HP, Krishnamoorthy R, Rathod M. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). J Biol Chem 2009;284:34538-34544.
6. Zu L, He J, Jiang H, Xu C, Pu S, Xu G. Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. J Biol Chem 2009; 284:5915-5926.
7. Zu L, Jiang H, He J, Xu C, Pu S, Liu M, Xu G. Salicylate blocks lipolytic actions of tumor necrosis factor-a in primary rat adipocytes. Mol Pharmacol 2008;73:215-223.
8. Xu C, He J, Jiang H, Zu L, ZhaiW, Pu S, Xu G. Direct effect of glucocorticoids on lipolysis in adipocytes. Mol Endocrinol 2009;23:1161-1170.
9. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 2001;98:6494-6499.
10. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, Gorenstein D, Chen KH, Chan L. Absence of perilipin results in leanness and reverses obesity in Leprdb/db mice. Nat Genet 2000;26:474-479.
11. ZhaiW, Xu C, Ling Y, Liu S, Deng J, Qi Y, Londos C, Xu G. Increased lipolysis in adipose tissues is associated with elevation of systemic free fatty acids and insulin resistance in perilipin null mice. Horm Metab Res 2010;42:247-253.
12. Gandotra S, Le Dour C, Bottomley W, Cervera P, Giral P, Reznik Y, Charpentier G, Auclair M, Delepine M, Barroso I, Semple RK, Lathrop M, Lascols O, Capeau J, O'Rahilly S, Magre J, Savage DB, Vigouroux C. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 2011;364:740-748.
13. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006;291:H1489-H1506.
14. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010;90:207-258.
15. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007;4:436-443.
16. Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ, Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res 1997;38:2249-2263.
17. DohmGL, Huston RL, AskewEW, Weiser PC. Effects of exercise on activity of heart and muscle mitochondria. Am J Physiol 1972;223:783-787.
18. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004;306: 1383-1386.
19. Suzuki J, Shen WJ, Nelson BD, Selwood SP, Murphy GM Jr, Kanehara H, Takahashi S, Oida K, Miyamori I, Kraemer FB. Cardiac gene expression profile and lipid accumulation in response to starvation. Am J Physiol Endocrinol Metab 2002;283:E94-E102.
20. King KL, Okere IC, Sharma N, Dyck JR, Reszko AE, McElfresh TA, Kerner J, Chandler MP, Lopaschuk GD, Stanley WC. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power. Am J Physiol Heart Circ Physiol 2005;289: H1033-H1037.
21. Wang H, Sreenivasan U, GongDW, O'Connell KA, Dabkowski ER, Hecker PA, Ionica N, Konig M, Mahurkar A, Sun Y, Stanley WC, Sztalryd C. Cardiomyocyte specific perilipin 5 overexpression leads to myocardial steatosis, and modest cardiac dysfunction. J Lipid Res 2013;54:953-965.
22. Kuramoto K, Okamura T, Yamaguchi T, Nakamura TY, Wakabayashi S, Morinaga H, Nomura M, Yanase T, Otsu K, Usuda N, Matsumura S, Inoue K, Fushiki T, Kojima Y, Hashimoto T, Sakai F, Hirose F, Osumi T. Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation. J Biol Chem 2012;287:23852-23863.
23. Wolins NE, Quaynor BK, Skinner JR, Tzekov A, Croce MA, Gropler MC, Varma V, Yao-Borengasser A, Rasouli N, Kern PA, Finck BN, Bickel PE. OXPAT/PAT-1 is a PPARinduced lipid droplet protein that promotes fatty acid utilization. Diabetes 2006;55: 3418-3428.
24. McManaman JL, Bales ES, Orlicky DJ, Jackman M, Maclean PS, Cain S, Crunk AE, Mansur A, Graham CE, Bowman TA, Greenberg AS. Perilipin-2 null mice are protected against diet-induced obesity, adipose inflammation and fatty liver disease. J Lipid Res 2013; 54:1346-1359.
25. Pollak NM, Schweiger M, Jaeger D, Kolb D, Kumari M, Schreiber R, Kolleritsch S, Markolin P, Grabner GF, Heier C, Zierler KA, Ruelicke T, Zimmermann R, Lass A, Zechner R, Haemmerle G. Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier. J Lipid Res 2013;54: 1092-1102.
26. ChenW, Chang B, Wu X, Li L, Sleeman M, Chan L. Inactivation of Plin4 downregulates Plin5 and reduces cardiac lipid accumulation in mice. Am J Physiol Endocrinol Metab 2013; 304:E770-E779.
27. Saha PK, Kojima H, Martinez-Botas J, Sunehag AL, Chan L. Metabolic adaptations in the absence of perilipin: increased b-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipinnull mice. J Biol Chem 2004;279:35150-35158.
28. Beylot M, Neggazi S, Hamlat N, Langlois D, Forcheron F. Perilipin 1 ablation in mice enhances lipid oxidation during exercise and does not impair exercise performance. Metabolism 2012;61:415-423.
29. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008;94:231-241.
30. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, GrossRW, KellyDP. A critical role for PPARa-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 2003;100:1226-1231.
31. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005;96:225-233.
32. Chiu HC, Kovacs A, FordDA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001;107:813-822.
33. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, Goldberg IJ. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 2003;111:419-426.
34. Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation 2004;109:1550-1557.
35. Hool LC. Reactive oxygen species in cardiac signalling: from mitochondria to plasma membrane ion channels. Clin Exp Pharmacol Physiol 2006;33:146-151.
36. Sorescu D, Griendling KK. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 2002;8: 132-140.
37. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004;53: 1336-1343.
38. Lupsa BC, Sachdev V, Lungu AO, Rosing DR, Gorden P. Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment. Medicine (Baltimore) 2010; 89:245-250.
39. Garg A. Adipose tissue dysfunction in obesity and lipodystrophy. Clin Cornerstone 2006;8 Suppl 4:S7-S13.
40. Mottagui-Tabar S, Ryden M, Lofgren P, Faulds G, Hoffstedt J, Brookes AJ, Andersson I, Arner P. Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia 2003;46:789-797.